Cucumber (Cucumis sativus L.) Fruit and Combination with Losartan Attenuate the Elevation of Blood Pressure in Hypertensive Rats Induced by Angiotensin II
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Cucumis sativus L. (C. sativus) is vegetable commonly used for managing blood pressure and often consumed in combination with standard antihypertensive therapy, despite lack of scientific evidence supporting their use. Combination of herbs and standard medication could have positive or negative effects. Therefore, this study aimed to evaluate the antihypertensive activity of C. sativus and the combined effect with losartan in the hypertensive rat model induced by angiotensin II. Angiotensin II is a component of the renin-angiotensin-aldosterone system that, upon binding to its receptor, constricts blood vessels leading to elevation of blood pressure. Methods: In an antihypertensive study, rats received C. sativus orally at doses of 9, 18, 27, and 36 mg/kg (full dose); while in a combination study, animals received losartan 2.25 mg/kg combined by either with C. sativus 9 or 18 mg/kg. The standards group received losartan 2.25 mg/kg or 4.5 mg/kg (full dose). Results: Blood pressure was measured using the tail-cuff method. C. sativus significantly attenuated angiotensin II-induced hypertension as observed in groups receiving C. sativus at 9, 18, 27, and 36 mg/kg at 30 minutes after induction showed the average change (Δ) of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with respect to time zero were 28.8/18.3, 24.8/15.8, 22.8/15.5, and 11.5/9.0 mmHg, respectively. Whereas the average change (Δ) of SBP and DBP in the rats receiving the combination of half doses of C. sativus and losartan were 8.8/9.0 mmHg, respectively. These diminished effects were better than a full dose of C. sativus and comparable with a full dose of losartan (6.5/7.8 mmHg). Conclusion: The present findings indicate that C. sativus dose-dependently blocks blood pressure elevation induced by angiotensin II. The combination of half dose of C. sativus and losartan has an additive effect in lowering blood pressure.
Abstract
Objectives: Cucumis sativus L. (C. sativus) is vegetable commonly used for managing blood pressure and often consumed in combination with standard antihypertensive therapy, despite lack of scientific evidence supporting their use. Combination of herbs and standard medication could have positive or negative effects. Therefore, this study aimed to evaluate the antihypertensive activity of C. sativus and the combined effect with losartan in the hypertensive rat model induced by angiotensin II. Angiotensin II is a component of the renin-angiotensin-aldosterone system that, upon binding to its receptor, constricts blood vessels leading to elevation of blood pressure. Methods: In an antihypertensive study, rats received C. sativus orally at doses of 9, 18, 27, and 36 mg/kg (full dose); while in a combination study, animals received losartan 2.25 mg/kg combined by either with C. sativus 9 or 18 mg/kg. The standards group received losartan 2.25 mg/kg or 4.5 mg/kg (full dose). Results: Blood pressure was measured using the tail-cuff method. C. sativus significantly attenuated angiotensin II-induced hypertension as observed in groups receiving C. sativus at 9, 18, 27, and 36 mg/kg at 30 minutes after induction showed the average change (Δ) of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with respect to time zero were 28.8/18.3, 24.8/15.8, 22.8/15.5, and 11.5/9.0 mmHg, respectively. Whereas the average change (Δ) of SBP and DBP in the rats receiving the combination of half doses of C. sativus and losartan were 8.8/9.0 mmHg, respectively. These diminished effects were better than a full dose of C. sativus and comparable with a full dose of losartan (6.5/7.8 mmHg). Conclusion: The present findings indicate that C. sativus dose-dependently blocks blood pressure elevation induced by angiotensin II. The combination of half dose of C. sativus and losartan has an additive effect in lowering blood pressure.
참고문헌 (39)
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Kearney PM, "Global burden of hypertension : analysis of worldwide data", Lancet, 365(9455), pp.217~223 (2005)
- NCD Risk Factor Collaboration, "Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479population-based measurement studies with 19·1 million participants", Lancet, 396(10255), pp.886~ (2020)
- Feng XL, "Health system strengthening and hypertension awareness, treatment and control : data from the China Health and Retirement Longitudinal Study", Bull World Health Organ, 92(1), pp.29~41 (2014)
- James PA, "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)", JAMA, 311(17), pp.1809~ (2014)
- Tabassum N, "Role of natural herbs in the treatment of hypertension", Pharmacogn Rev, 5(9), pp.30~40 (2011)
- Mansoor GA, "Herbs and alternative therapies in the hypertension clinic", Am J Hypertens, 14(9 Pt 1), pp.971~975 (2001)
- Kamyab R, "Medicinal plants in the treatment of hypertension : a review", Adv Pharm Bull, 11(4), pp.601~617 (2021)
- Al Disi SS, "Anti-hypertensive herbs and their mechanisms of action : part I", Front Pharmacol, 6, pp.323~ (2016)
- Yuan RQ, "Cucurbitacins extracted from Cucumis melo L. (CuEC) exert a hypotensive effect via regulating vascular tone", Hypertens Res, 42(8), pp.1152~1161 (2019)
- Mali VR, "Antihypertensive and cardioprotective effects of the Lagenaria siceraria fruit in NG-nitro-L-arginine methyl ester (L-NAME) induced hypertensive rats", Pharm Biol, 50(11), pp.1428~1435 (2012)
- Trejo-Moreno C, "Cucumis sativus aqueous fraction inhibits angiotensin ii-induced inflammation and oxidative stress in vitro", Nutrients, 10(3), pp.276~ (2018)
- Palanisamy V, "Evaluation of diuretic activity of polyherbal formulation", Int J Pharm, 5(1), pp.244~247 (2015)
- Teixeira K, "Medicinal plants that can cause changes in blood pressure and interactions with antihypertensive agents", Am J Ethnomed, 4(1), pp.1~8 (2017)
- Nana FW, "Phytochemical composition, antioxidant and xanthine oxidase inhibitory activities of Amaranthus cruentus L. and Amaranthus hybridus L. extracts", Pharmaceuticals (Basel), 5(6), pp.613~628 (2012)
- Kamkar-Del Y, "Ethyl acetate and aqueous fractions of Ziziphus jujuba prevent acute hypertension induced by angiotensin II in rats", Cardiovasc Hematol Disord Drug Targets, 20(2), pp.108~115 (2020)
- Kazemi F, "Antihypertensive effects of standardized asafoetida: effect on hypertension induced by angiotensin II", Adv Biomed Res, 9, pp.77~ (2020)
- Luft FC, "Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins", Hypertension, 14(4), pp.396~403 (1989)
- Diz DI, "Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins", J Clin Invest, 72(2), pp.466~477 (1983)
- Loiola RA, "Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats", Peptides, 32(10), pp.2116~2121 (2011)
- Zhang F, "Angiotensin-(1-7)induced vascular relaxation in spontaneously hypertensive rats", Nitric Oxide, 88, pp.1~9 (2019)
- Rajagopalan S, "Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH", NADPH oxidase activation. Contribution to alterations of vasomotor tone, 1996, pp.97(8), 1916~1923
- Lever AF, "Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels?", J Hypertens, 4(5), pp.515~524 (1986)
- Kumar D, "Free radical scavenging and analgesic activities of Cucumis sativus L. fruit extract", J Young Pharm, 2(4), pp.365~368 (2010)
- Tuama AA, "Phytochemical screening and in vitro antibacterial and anticancer activities of the aqueous extract of Cucumis sativus", Saudi J Biol Sci, 26(3), pp.600~604 (2019)
- Liang J, "Advances in research on the anticancer mechanism of the natural compound cucurbitacin from Cucurbitaceae plants : a review", Tradit Med Res, 4(2), pp.68~81 (2019)
- Krauze-Baranowska M, "Flavonoids from some species of the genus Cucumis", Biochem Syst Ecol, 29(3), pp.321~324 (2001)
- Clark JL, "Efficacy of flavonoids in the management of high blood pressure", Nutr Rev, 73(12), pp.799~822 (2015)
- Ciumărnean L, "The effects of flavonoids in cardiovascular diseases", Molecules, 25(18), pp.4320~ (2020)
- Tettey CO, "Vasodilatory effect of kaempferol-7-O-α-L-rhamnopyranoside via NO-cGMP-PKG signaling", Arch Biochem Biophys, 667, pp.1~5 (2019)
- Serban MC, "Effects of quercetin on blood pressure : a systematic review and meta-analysis of randomized controlled trials", J Am Heart Assoc, 5(7), pp.e002713~ (2016)
- Karmazyn M, "Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension", Mol Cell Biochem, 476(1), pp.333~347 (2021)
- Niyi O, "Comparative assessment of the proximate, mineral composition and mineral safety index of peel, pulp and seeds of cucumber(Cucumis sativus)", Open J Appl Sci, 9(9), pp.691~701 (2019)
- Houston MC, "Potassium, magnesium, and calcium : their role in both the cause and treatment of hypertension", J Clin Hypertens(Greenwich), 10(7 Suppl 2), pp.3~11 (2008)
- Mousavi SM, "The effect of zinc supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized-controlled trials", Eur J Nutr, 59(5), pp.1829~ (2020)
- Olechnowicz J, "Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism", J Physiol Sci, 68(1), pp.19~31 (2018)
- Förstermann U, "Nitric oxide synthases : regulation and function", Eur Heart J, 33(7), pp.829~837 (2012)
- Benjamin N, "Nitric oxide and hypertension", Circulation, 94(6), pp.1197~1198 (1996)
- Roell KR, "An introduction to terminology and methodology of chemical synergy-perspectives from across disciplines", Front Pharmacol, 8, pp.158~ (2017)